Correlation between total and CD4 lymphocyte counts in HIV infection: Not making the good an enemy of the not so perfect

International Journal of STD and AIDS

Volumn 7, Issue 6, 1996, Pages 422-428

  Beck, E J ^a   Kupek, E J ^a   Gompels, M M ^b   Pinching, A J ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Average cost; CD4 lymphocyte count; HIV 1 infection; Total lymphocyte count

Indexed keywords

CD4 ANTIGEN;

ARTICLE; CONTROLLED STUDY; FINANCIAL MANAGEMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; LYMPHOCYTE COUNT;

EID: 0029826852     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462961918392     Document Type: Article

References (34)

1. CDC Kaposi's sarcoma and pneumocystis pneumonia among homosexual males - New York City and California. MMWR 1981;20:305-8
2. Masur H, Michelis MA, Greene JB, et al. An outbreak of community-acquired P. carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981;305:1431-8
3. Fauci AS, Macher AM, Longo DL, et al. Acquired immuno-deficiency syndrome: epidemiologic, clinical, immunologie and therapeutic considerations. Ann Intern Med 1984;100: 92-106
4. Bowen DL, Lane HC, Fauci AS. Immunopathogenesis of the acquired immunodeficiency syndrome. Ann Int Med 1985;103:704-9
5. Philips AN, Lee CA, Elford J, et al. Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991;337(I):389-92
6. Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis 1992;165:352-63
7. Graham NMH, Piantadosi S, Park LP, Phair JP, Rinaldo CR, Fahey JL. CD4 lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time. J AIDS 1993;6:1258-66
8. Concorde Coordinating Committee. Concorde: MRC/ANRS randomized double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994;343:871-81
9. Schechter M, Zajdenverg R, Machado LL, et al. Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging system. J AIDS 1994;7:163-8
10. The WHO International Collaborating Group for the Study of the WHO Staging System. Proposed 'World Health Organization Staging System for HIV Infection and Disease': preliminary testing by an international collaborative cross-sectional study. AIDS 1993;7:711-18
11. Beck EJ, McKevitt C, Kennelly J, Whitaker L, Wadsworth J, Miller DL. Hospital Service Provision for People with AIDS and HIV Infection: a report for the Department of Health 1991. Academic Department of Public Health, St Mary's Hospital Medical School, London, UK, 1991
12. Beck EJ, Whitaker L, Kennelly J, et al. Changing presentation and survival, service utilization and costs for AIDS patients: insights from a London referral centre. AIDS 1994;8:379-84
13. CDSC. Aids Surveillance and HIV Death Clinical Report Form. PHLS Communicable Disease Surveillance Centre, London, April 1989
14. Gelman R, Eudey L. Biostatistical considerations for quality assessment of immunologic measurements used in clinical and longitudinal studies. Clin Immunol Immunopath 1989;52:28-37
15. Kidd PG, Vogt RF. Report of the evaluation of T-cell subsets during HIV infection and AIDS. Clin Immunol Immunopath 1989;52:3-9
16. Rumke CL. Variability of results in differential cell counts on blood smears. Triangle 1960;4:154-8
17. Koepke JA, Landay AL. Precision and accuracy of absolute lymphocyte counts. Clin Immunol Immunopath 1989;52:19-27
18. Kidd PG, Cheng SC, Paxton H, Landay A, Gelman R. Prediction of CD4 count from CD4 percentages: experience from three laboratories. AIDS 1993;7:933-40
19. Taylor JMG, Fahey JL, Detels R, Giorgi JV. CD4 percentage, CD4 number, and CD4: CDS ratio in HIV infection: which to choose and how to use. J AIDS 1989;2:114-24
20. Malone JL, Simms TE, Gray GC, Wagner KF, Burge JR, Burke DS. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1 infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J AIDS 1990;3:144-51
21. Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis 1992;165:352-63
22. Raboud JM, Huthey L, Montaner JSG, Murphy C, Janaverwska M, Schechter MT. Reducing the variation in CD4 lymphocyte count measurements. Abstract PB0082, X International Conference on AIDS, Yokohama, August 1994
23. Fournier AM, Sosenko JM. The relationship of total lymphocyte count to CD4 lymphocyte counts in patients infected with human immunodeficiency virus. Am J Med Sci 1992;304:79-82
24. Giorgi JV, Detels R. T-cell subset alterations in HIV-infected homosexual men: NIAID multicentre AIDS cohort study. Clin Immunol Immunopath 1989;52:10-18
25. Cuthbert RJG, Ludlam CA, Tucker J, et al. Five year prospective study of HIV infection in the Edinburgh haemophiliac cohort. BMJ 1990;301:956-61
26. Anderson RE, Shiboski SC, Royce R, Jewell NP, Lang W, Winkelstein Jr W. CD8+ T lymphocytes and progression to AIDS in HIV-infected men: some observations. AIDS 1991;5:213-15
27. Chevret S, Roquin H, Ganne P, Lefrere JJ. Prognostic value of an elevated CDS lymphocyte count in HIV infection: results of a prospective study of 152 asymptomatic HIV-positive individuals. AIDS 1992;6:1349-52
28. Lai KK. Correlation of absolute lymphocyte count with CD4 counts in HIV-infected patients. Abstract PO B03-0988, IX International Conference on AIDS, Berlin, June 1993
29. Pulido F, Rubio R, Castilla V, Sanchez-Manzano MD, Mateos R, Costa JR. Value of total lymphocyte count to start prophylaxis against P. carinii pneumonia. Abstract PO B10-1462, IX International Conference on AIDS, Berlin, June 1993
30. Montaner JSG, Le TN, Le N, Craib KJP, Schechter MT. Application of the World Health Organization system for HIV infection in a cohort of homosexual men in developing a prognostically meaningful staging system. AIDS 1992;6: 719-24
31. Lima LAA, May SB, Perez MA, Schechter M. Survival of HIV-infected Brazilians: a model based on the World Health Organization staging system. AIDS 1993;7: 296-6
32. Beck EJ. HIV-infection and intervention: the first decade. AIDS Care 1991;3:295-302
33. Johnson AM, De Cock KM. What's happening to AIDS? BMJ 1994;309:1523-4
34. Berkley S, Piot P, Schopper D. AIDS: invest now or pay more later. Finance Develop 1994;31(2):40-3